Interactions médicamenteuses
Blinatumomab + Ethosuximide
Gravité: Modérée
Blinatumomab and Ethosuximide: moderate interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Blinatumomab causes transient cytokine release that can suppress CYP enzymes, potentially raising levels of ethosuximide. The risk is greatest during the first days of treatment cycles.
Ce que signifie cette interaction, en termes simples
Blinatumomab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Blinatumomab belongs to Oncology; Ethosuximide belongs to Central Nervous System.
Pourquoi elle survient
Cytokine-mediated transient suppression of CYP450 enzymes reduces ethosuximide metabolism.
Conduite à tenir
Monitor for ethosuximide toxicity such as drowsiness, nausea and ataxia during the first days of each cycle, and check drug levels if symptomatic.
Questions à poser à votre pharmacien
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Blinatumomab et Ethosuximide, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres interactions de Ethosuximide
- Benzhydrocodone / acetaminophen + Ethosuximide Majeure
- Buprenorphine long-acting + Ethosuximide Majeure
- Buprenorphine subdermal implant + Ethosuximide Majeure
- Buprenorphine transdermal + Ethosuximide Majeure
- Calcium / magnesium / potassium / sodium oxybates + Ethosuximide Majeure
- Ethosuximide + Fentanyl intranasal Majeure
Autres interactions de Blinatumomab
- Blinatumomab + Carbamazepine Modérée
- Blinatumomab + Cyclosporin Modérée
- Blinatumomab + Phenytoin Modérée
- Blinatumomab + Quinidine Modérée
- Blinatumomab + Quinine Modérée
- Blinatumomab + Siponimod Modérée
Questions fréquentes
Can I take Blinatumomab with Ethosuximide?
MediHelp rates the interaction as moderate. Blinatumomab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab causes transient cytokine release that can suppress CYP enzymes, potentially raising levels of ethosuximide. The risk is greatest during the first days of treatment cycles.
How serious is the interaction between Blinatumomab and Ethosuximide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ethosuximide toxicity such as drowsiness, nausea and ataxia during the first days of each cycle, and check drug levels if symptomatic.
What other medicines interact with Ethosuximide?
MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
